A. Volkmann et al., ANTAGONIST PEPTIDE SELECTS THYMOCYTES EXPRESSING A CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED T-CELL RECEPTOR INTO THE CD8 LINEAGE, The Journal of experimental medicine, 188(6), 1998, pp. 1083-1089
CD4/CD8 lineage decision is an important event during T cell maturatio
n in the thymus. CD8 T cell differentiation usually requires corecogni
tion of major histocompatibility complex (MHC) class I by the T cell r
eceptor (TCR) and CD8, whereas CD4 T cells differentiate as a conseque
nce of MHC class IT recognition by the TCR and CD4. The involvement of
specific peptides in the selection of T cells expressing a particular
TCR could be demonstrated so far for the CD8 lineage only. We used mi
ce transgenic for an MHC class II-restricted TCR to investigate the ro
le of antagonistic peptides in CD4 T cell differentiation. Interesting
ly, antagonists blocked the development of CD4(+) cells that normally
differentiate in thymus organ culture from those mice, and they induce
d the generation of CD8(+) cells in thymus organ culture from mice imp
aired in CD4+ cell development (invariant chain-deficient mice). These
results are in line with recent observations that antagonistic signal
s direct differentiation into the CD8 lineage, regardless of MHC speci
ficity.